Background: Atrial tachycardia is a troublesome and medically refractory complication after surgery for atrial fibrillation. Incomplete surgical ablation during atrial fibrillation surgery can result in residual conduction over the lesions and postoperative atrial tachycardia. Intraoperative verification of conduction block would detect incomplete ablation lesions and direct repeat ablations to prevent postoperative atrial tachycardia.
Methods: The incidence of postoperative atrial tachycardia was examined in 218 patients who underwent atrial fibrillation surgery between November of 1994 and October of 2007. No conduction block across any ablation lesions was confirmed intraoperatively in the first 128 patients (group C). Isolation of each pulmonary vein was verified by intraoperative pulmonary vein pacing in the following 72 patients (group PV). In the recent 18 consecutive patients, conduction block in the coronary sinus, in addition to pulmonary vein isolation, was confirmed by intraoperative coronary sinus pacing (group PV/CS). Postoperative atrial tachycardia was characterized by electroanatomic mapping.
Results: The incidence of postoperative atrial tachycardia in groups C and PV was 7% and 1%, respectively (P = .0985). No patients exhibited any postoperative atrial tachycardia in group PV/CS. The postoperative electroanatomic mapping revealed that the mechanisms of the atrial tachycardia were macro-reentry through incomplete coronary sinus and mitral valve ablation lesions (n = 9), and focal activation in the coronary sinus (n = 1). Intraoperative verification of conduction block directed the repeat ablation lesions to the pulmonary veins.
Conclusion: The majority of postoperative atrial tachycardia was associated with an incomplete coronary sinus ablation. Intraoperative verification of conduction block may be helpful to prevent the occurrence of postoperative atrial tachycardia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jtcvs.2008.06.022 | DOI Listing |
Curr Cardiol Rep
January 2025
Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Purpose Of Review: This review aims to explore how a diagnosis of LMNA-related cardiomyopathy (LMNA-CM) informs clinical management, focusing on the prevention and management of its complications, through practical clinical strategies.
Recent Findings: Longitudinal studies have enhanced our understanding of the natural history of LMNA-CM including its arrhythmic and non-arrhythmic complications. A LMNA specific ventricular arrhythmia risk prediction strategy has been integrated into clinical practice guidelines.
J Cardiovasc Electrophysiol
January 2025
Sakakibara Kinen Byoin, Fuchu, Japan.
Introduction: Freedom from recurrences of atrial tachyarrhythmia (ATA) is suboptimal after pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (PsAF). This sub-analysis from the Cryo Global Registry sought to investigate predictors of ablation success after PVI using cryoballoon ablation (CBA) for PsAF.
Methods And Results: ATA recurrence was defined as ≥ 30 s recurrence of atrial fibrillation, atrial flutter or atrial tachycardia after a 90-day blanking period and through 12-months.
Eur J Clin Invest
January 2025
Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) commonly leads to heart failure but has traditionally been an exclusion criterion in randomized clinical trials (RCTs) of sodium-glucose cotransporter 2 inhibitors (SGLT2i); therefore, the effects of these drugs in this population remain undocumented. In light of recent studies, this meta-analysis aimed to investigate the effect of SGLT2i on the prognosis of patients with ATTR-CM.
Methods: A comprehensive search of Medline, Scopus, and the Cochrane Library was conducted up to November 17, 2024.
Int J Cardiol Heart Vasc
February 2025
Division of Electrophysiology, Department of Cardiology, UPMC Harrisburg, PA 17101, United States.
Cureus
December 2024
Department of Obstetrics and Gynecology, Sakakibara Heart Institute, Fuchu, JPN.
Preterm birth remains a leading cause of neurodevelopmental disability in offspring, prompting various preventive measures. However, controversies persist surrounding these approaches, particularly regarding beta-mimetic drugs. In Japan, it remains a concerning reality that ritodrine infusion continues to be used for long-term tocolysis in preterm labor, despite the warning issued by the US Food and Drug Administration.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!